Pefloxacin mesylate (BioDeep_00000398981)

   

natural product


代谢物信息卡片


Pefloxacin mesylate

化学式: C18H24FN3O6S (429.1369776)
中文名称: 甲磺酸培氟沙星
谱图信息: 最多检出来源 Escherichia coli(natural_products) 55.56%

分子结构信息

SMILES: C1(=C(C=C2C(=C1)C(C(=CN2CC)C(=O)O)=O)N3CCN(CC3)C)F.S(C)(=O)(=O)O
InChI: 1H3,(H,2,3,4)

描述信息

L - Antineoplastic and immunomodulating agents > L03 - Immunostimulants > L03A - Immunostimulants > L03AA - Colony stimulating factors
D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors
D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones
C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic

同义名列表

1 个代谢物同义名

Pefloxacin mesylate



数据库引用编号

10 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Junjun Feng, Haiyun Jiang, Jing Wang, Zhengyi Jing, Fan Zhang, Tianyu Tan, Feng He, Lihua Jiang, Haiqin Li, Shimin Chang, Tengfei Li. [Simultaneous determination of 40 plant growth regulators, fungicides, insecticides, and antibiotics in bean sprouts by QuEChERS-high performance liquid chromatography-tandem mass spectrometry]. Se pu = Chinese journal of chromatography. 2022 Sep; 40(9):843-853. doi: 10.3724/sp.j.1123.2021.12028. [PMID: 36156631]
  • Wanling Cai, Xiulan Weng, Wei Zhang, Zuliang Chen. Green magnetic nanomaterial as antibiotic release vehicle: The release of pefloxacin and ofloxacin. Materials science & engineering. C, Materials for biological applications. 2021 Jan; 118(?):111439. doi: 10.1016/j.msec.2020.111439. [PMID: 33255032]
  • Sivaramakrishnan Ramadurai, Nirod Kumar Sarangi, Sean Maher, Nicola MacConnell, Alan M Bond, Dennis McDaid, Damien Flynn, Tia E Keyes. Microcavity-Supported Lipid Bilayers; Evaluation of Drug-Lipid Membrane Interactions by Electrochemical Impedance and Fluorescence Correlation Spectroscopy. Langmuir : the ACS journal of surfaces and colloids. 2019 06; 35(24):8095-8109. doi: 10.1021/acs.langmuir.9b01028. [PMID: 31120755]
  • Xiuyuan Zhang, Kuo He, Donghao Zhang, Zhihong Huang. Production and characterization of a monoclonal antibody for Pefloxacin and mechanism study of antibody recognition. Bioscience, biotechnology, and biochemistry. 2019 Apr; 83(4):633-640. doi: 10.1080/09168451.2018.1562876. [PMID: 30618329]
  • Lei Sha, Xiaoyan Tang, Dengyong Liu, Yongping Xu, Y U Ding, Feng Ding. Detection and Quantitation of Lomefloxacin and Pefloxacin Residues in the Organ Tissues and Eggs of Laying Hens. Journal of food protection. 2018 05; 81(5):810-814. doi: 10.4315/0362-028x.jfp-17-422. [PMID: 29637810]
  • Shuqian Lin, Guiming Li, Zengcheng Zhao, Jian Fu, Minyan Feng, Minxun Song, Zhongli Huang, Shifa Yang, Shuli Wang, Renzhong Wan. Pharmacokinetics and tissue distribution of pefloxacin mesylate in chickens. Biomedical chromatography : BMC. 2018 Apr; 32(4):. doi: 10.1002/bmc.4154. [PMID: 29178369]
  • Haitao Hu, Kishore Kumar Katyayan, Boris A Czeskis, Everett J Perkins, Palaniappan Kulanthaivel. Comparison between Radioanalysis and 19F Nuclear Magnetic Resonance Spectroscopy in the Determination of Mass Balance, Metabolism, and Distribution of Pefloxacin. Drug metabolism and disposition: the biological fate of chemicals. 2017 04; 45(4):399-408. doi: 10.1124/dmd.116.073809. [PMID: 28188298]
  • Nuggehally R Srinivas. Interspecies scaling of excretory amounts using allometry - retrospective analysis with rifapentine, aztreonam, carumonam, pefloxacin, miloxacin, trovafloxacin, doripenem, imipenem, cefozopran, ceftazidime, linezolid for urinary excretion and rifapentine, cabotegravir, and dolutegravir for fecal excretion. Xenobiotica; the fate of foreign compounds in biological systems. 2016 Sep; 46(9):784-92. doi: 10.3109/00498254.2015.1121554. [PMID: 26711252]
  • Robert Skov, Erika Matuschek, Maria Sjölund-Karlsson, Jenny Åhman, Andreas Petersen, Marc Stegger, Mia Torpdahl, Gunnar Kahlmeter. Development of a Pefloxacin Disk Diffusion Method for Detection of Fluoroquinolone-Resistant Salmonella enterica. Journal of clinical microbiology. 2015 Nov; 53(11):3411-7. doi: 10.1128/jcm.01287-15. [PMID: 26292292]
  • Solomon O Rotimi, David A Ojo, Olusola A Talabi, Regina N Ugbaja, Elizabeth A Balogun, Oladipo Ademuyiwa. Amoxillin- and pefloxacin-induced cholesterogenesis and phospholipidosis in rat tissues. Lipids in health and disease. 2015 Feb; 14(?):13. doi: 10.1186/s12944-015-0011-8. [PMID: 25879817]
  • Shahnaz Gauhar, Syed Ayub Ali, Syed Baqir Naqvi, Muhammad Harris Shoaib. Report: pharmacokinetic and drug interaction studies of pefloxacin with paracetamol (NNAID) in healthy volunteers in Pakistan. Pakistan journal of pharmaceutical sciences. 2014 Mar; 27(2):389-95. doi: NULL. [PMID: 24577931]
  • Aiyun Li, Zhiqiang Song. Study of silver nanoparticles sensitized fluorescence and second-order scattering of terbium(III)-pefloxacin mesylate complex and determination of pefloxacin mesylate. TheScientificWorldJournal. 2014; 2014(?):742935. doi: 10.1155/2014/742935. [PMID: 24892083]
  • J A Murillo Pulgarín, A Alañón Molina, N Boras. Application of non-linear angle synchronous spectrofluorimetry to the determination of complex mixtures of drugs in urine: a comparative study. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy. 2012 Dec; 98(?):190-8. doi: 10.1016/j.saa.2012.07.095. [PMID: 23021891]
  • Solomon O Rotimi, David A Ojo, Olusola A Talabi, Elizabeth A Balogun, Oladipo Ademuyiwa. Tissue dyslipidemia in Salmonella-infected rats treated with amoxillin and pefloxacin. Lipids in health and disease. 2012 Nov; 11(?):152. doi: 10.1186/1476-511x-11-152. [PMID: 23137290]
  • J Madan, D Kaushik, S Sardana, A Ali, M Sudhakaran Sudheesh, R Shankar Pandey. Effect of levofloxacin and pefloxacin on humoral immune response elicited by bovine serum albumin docked in gelatin microparticles and nanoparticles. Die Pharmazie. 2010 Apr; 65(4):284-9. doi: NULL. [PMID: 20432626]
  • Biyang Deng, Linqiu Li, Aihong Shi, Yanhui Kang. Pharmacokinetics of pefloxacin mesylate in human urine using capillary electrophoresis electrochemiluminescence detection. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2009 Aug; 877(24):2585-8. doi: 10.1016/j.jchromb.2009.06.021. [PMID: 19576860]
  • Hanwen Sun, Peiyun Chen, Fei Wang, Haifang Wen. Investigation on enhanced chemiluminescence reaction systems with bis(hydrogenperiodato) argentate(III) complex anion for fluoroquinolones synthetic antibiotics. Talanta. 2009 Jul; 79(2):134-40. doi: 10.1016/j.talanta.2009.03.008. [PMID: 19559854]
  • Ayman Goudah, Syed Sher Shah, Ho-Chul Shin, Byung-Joon Chang, Jae-Han Shim, A M Abd El-Aty. Concentration-time courses of pefloxacin in plasma and milk of lactating she-camels (Camelus dromedarius). Berliner und Munchener tierarztliche Wochenschrift. 2008 Nov; 121(11-12):432-9. doi: NULL. [PMID: 19086693]
  • Yongnian Ni, Yong Wang, Serge Kokot. Multicomponent kinetic spectrophotometric determination of pefloxacin and norfloxacin in pharmaceutical preparations and human plasma samples with the aid of chemometrics. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy. 2008 Oct; 70(5):1049-59. doi: 10.1016/j.saa.2007.10.013. [PMID: 18060832]
  • Madhukar S Dama, C Varshneya, M S Dardi, V C Katoch. Effect of trikatu pretreatment on the pharmacokinetics of pefloxacin administered orally in mountain Gaddi goats. Journal of veterinary science. 2008 Mar; 9(1):25-9. doi: 10.4142/jvs.2008.9.1.25. [PMID: 18296885]
  • Bengi Uslu, Burcu Dogan Topal, Sibel A Ozkan. Electroanalytical investigation and determination of pefloxacin in pharmaceuticals and serum at boron-doped diamond and glassy carbon electrodes. Talanta. 2008 Feb; 74(5):1191-200. doi: 10.1016/j.talanta.2007.08.023. [PMID: 18371769]
  • Ji-cai Fan, Xiang Chen, Yun Wang, Cheng-ping Fan, Zhi-cai Shang. Binding interactions of pefloxacin mesylate with bovine lactoferrin and human serum albumin. Journal of Zhejiang University. Science. B. 2006 Jun; 7(6):452-8. doi: 10.1631/jzus.2006.b0452. [PMID: 16691639]
  • J Mohan, K V H Sastry, J S Tyagi, G S Rao, R V Singh. Residues of fluoroquinolone drugs in the cloacal gland and other tissues of Japanese quail. British poultry science. 2006 Feb; 47(1):83-7. doi: 10.1080/00071660500468173. [PMID: 16546801]
  • S Pant, G S Rao, K V H Sastry, H C Tripathi, Jagmohan, J K Malik. Pharmacokinetics and tissue residues of pefloxacin and its metabolite norfloxacin in broiler chickens. British poultry science. 2005 Oct; 46(5):615-20. doi: 10.1080/00071660500255323. [PMID: 16359117]
  • Cristina Tuchiluş, Antonia Poiată, Ioana Bădicuţ, D Buiuc. [Susceptibility to norfloxacin of some bacterial strains causing urinary infections]. Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi. 2005 Apr; 109(2):383-6. doi: . [PMID: 16607805]
  • A Radi, M A El Ries, S Kandil. Spectroscopic and voltammetric studies of pefloxacin bound to calf thymus double-stranded DNA. Analytical and bioanalytical chemistry. 2005 Jan; 381(2):451-5. doi: 10.1007/s00216-004-2882-9. [PMID: 15657711]
  • Gui-zhi Li, Yong-ming Liu, Gai-zhi Li. [Study on fluorescence characteristics of pefloxacin-La(III) complex and its application]. Guang pu xue yu guang pu fen xi = Guang pu. 2004 Sep; 24(9):1086-8. doi: NULL. [PMID: 15762529]
  • Orish E Orisakwe, Dora N Akunyili, Patrick U Agbasi, Ndidi A Ezejiofor. Some plasma and saliva pharmacokinetics parameters of rifampicin in the presence of pefloxacin. American journal of therapeutics. 2004 Jul; 11(4):283-7. doi: 10.1097/01.mjt.0000117523.18923.4a. [PMID: 15266220]
  • Li-Ming Du, Jing-ping Wang, Cai-xia Wang. [The fluorescence characteristics of micelle inclusion of pefloxacin and its application]. Guang pu xue yu guang pu fen xi = Guang pu. 2004 Jul; 24(7):855-7. doi: NULL. [PMID: 15766090]
  • Orish E Orisakwe, Patrick U Agbasi, Sabinus I Ofoefule, Ndidi A Ilondu, Onyenmechi J Afonne, Chikere A Anusiem, Cajetan E Ilo, Steve O Maduka. Effect of pefloxacin on the urinary excretion of rifampicin. American journal of therapeutics. 2004 Jan; 11(1):13-6. doi: 10.1097/00045391-200401000-00006. [PMID: 14704591]
  • A R Gascón, G Gutiérrez-Aragón, R M Hernández, J Errasti, J L Pedraz. Pharmacokinetics and tissue penetration of pefloxacin plus metronidazole after administration as surgical prophylaxis in colorectal surgery. International journal of clinical pharmacology and therapeutics. 2003 Jun; 41(6):267-74. doi: 10.5414/cpp41267. [PMID: 12816179]
  • S Ewig, P Tuschy, G Fätkenheuer. [Diagnosis and treatment of legionella pneumonia]. Pneumologie (Stuttgart, Germany). 2002 Nov; 56(11):695-703. doi: 10.1055/s-2002-35548. [PMID: 12442211]
  • A M Abd El-Aty, A Goudah. Some pharmacokinetic parameters of pefloxacin in lactating goats. Veterinary research communications. 2002 Oct; 26(7):553-61. doi: 10.1023/a:1020243615928. [PMID: 12416870]
  • A R Gascón, E Campo, E Olea, R M Hernández, B Calvo, J Errasti, J L Pedraz. Pharmacokinetics and tissue distribution of intravenous pefloxacin for antibiotic prophylaxis in biliary surgery. Biopharmaceutics & drug disposition. 2002 Oct; 23(7):293-300. doi: 10.1002/bdd.321. [PMID: 12355580]
  • J K Malik, G S Rao, S Ramesh, S Muruganandan, H C Tripathi, D C Shukla. Pharmacokinetics of pefloxacin in goats after intravenous or oral administration. Veterinary research communications. 2002 Feb; 26(2):141-9. doi: 10.1023/a:1014047702196. [PMID: 11922483]
  • L Ma, C Sun, J Wu. [Study of pefloxacin concentration in blood and sputum in the aged pneumonia patients with impairment of renal function]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases. 2001 Oct; 24(10):596-8. doi: NULL. [PMID: 11770420]
  • P L Wang, L Chen, Y F Fan. Selective separation and simultaneous determination of trace levels of five types of fluorinated quinolone drugs by thin-layer chromatography/fluorescence densitometry. Journal of AOAC International. 2001 May; 84(3):684-8. doi: 10.1093/jaoac/84.3.684. [PMID: 11417631]
  • A Giannopoulos, G Koratzanis, E J Giamarellos-Bourboulis, I Stinios, M Chrisofos, M Giannopoulou, H Giamarellou. Pharmacokinetics of intravenously administered pefloxacin in the prostate; perspectives for its application in surgical prophylaxis. International journal of antimicrobial agents. 2001 Mar; 17(3):221-4. doi: 10.1016/s0924-8579(00)00332-0. [PMID: 11282268]
  • S I Ofoefule, O E Onyeagba, O E Orisakwe. Effects of pefloxacin on urinary and salivary concentrations of isoniazid in six healthy female volunteers. American journal of therapeutics. 2000 Sep; 7(5):313-6. doi: 10.1097/00045391-200007050-00008. [PMID: 11317177]
  • A K Srivastava, V K Dumka, S S Deol. Disposition kinetics and urinary excretion of pefloxacin after intravenous injection in crossbred calves. Veterinary research communications. 2000 Apr; 24(3):189-96. doi: 10.1023/a:1006408415431. [PMID: 10836277]
  • M A Simonin, P Gegout-Pottie, A Minn, P Gillet, P Netter, B Terlain. Pefloxacin-induced achilles tendon toxicity in rodents: biochemical changes in proteoglycan synthesis and oxidative damage to collagen. Antimicrobial agents and chemotherapy. 2000 Apr; 44(4):867-72. doi: 10.1128/aac.44.4.867-872.2000. [PMID: 10722483]
  • A Trichilis, C Tesserommatis, D Varonos. Changes in serum levels of quinolones in rats under the influence of experimental trauma. European journal of drug metabolism and pharmacokinetics. 2000 Apr; 25(2):73-8. doi: 10.1007/bf03190070. [PMID: 11112085]
  • M A Simonin, P Gegout-Pottie, A Minn, P Gillet, P Netter, B Terlain. Proteoglycan and collagen biochemical variations during fluoroquinolone-induced chondrotoxicity in mice. Antimicrobial agents and chemotherapy. 1999 Dec; 43(12):2915-21. doi: 10.1128/aac.43.12.2915. [PMID: 10582882]
  • P Gratteri, G Cruciani. Experimental design and multivariate calibration in the development, set-up and validation of a differential pulse polarographic and UV spectrophotometric method for the simultaneous plasmatic determination of the therapeutic metronidazole-pefloxacin combination. The Analyst. 1999 Nov; 124(11):1683-8. doi: 10.1039/a905038h. [PMID: 10746324]
  • F Kozjek, L J Suturkova, G Antolic, I Grabnar, A Mrhar. Kinetics of 4-fluoroquinolones permeation into saliva. Biopharmaceutics & drug disposition. 1999 May; 20(4):183-91. doi: 10.1002/(sici)1099-081x(199905)20:4<183::aid-bdd178>3.0.co;2-b. [PMID: 10440793]
  • J A Bagon. Neuropsychiatric complications following quinolone overdose in renal failure. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 1999 May; 14(5):1337. doi: 10.1093/ndt/14.5.1337a. [PMID: 10344402]
  • D Elkharrat, C Chastang, M Boudiaf, A Le Corre, L Raskine, C Caulin. Relevance in the emergency department of a decisional algorithm for outpatient care of women with acute pyelonephritis. European journal of emergency medicine : official journal of the European Society for Emergency Medicine. 1999 Mar; 6(1):15-20. doi: NULL. [PMID: 10340729]
  • M Kinzig-Schippers, U Fuhr, M Zaigler, J Dammeyer, G Rüsing, A Labedzki, J Bulitta, F Sörgel. Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2. Clinical pharmacology and therapeutics. 1999 Mar; 65(3):262-74. doi: 10.1016/s0009-9236(99)70105-0. [PMID: 10096258]
  • M Jelikić-Stankov, D Stankov, P Djurdjević. Determination of pefloxacin in serum by time-resolved fluorimetry. Die Pharmazie. 1999 Jan; 54(1):73-4. doi: NULL. [PMID: 9987802]
  • K G Naber, U Theuretzbacher, M Kinzig, O Savov, F Sörgel. Urinary excretion and bactericidal activities of a single oral dose of 400 milligrams of fleroxacin versus a single oral dose of 800 milligrams of pefloxacin in healthy volunteers. Antimicrobial agents and chemotherapy. 1998 Jul; 42(7):1659-65. doi: 10.1128/aac.42.7.1659. [PMID: 9661000]
  • L M Levasseur, A Delon, W R Greco, P Faury, S Bouquet, W Couet. Development of a new quantitative approach for the isobolographic assessment of the convulsant interaction between pefloxacin and theophylline in rats. Pharmaceutical research. 1998 Jul; 15(7):1069-76. doi: 10.1023/a:1011938429379. [PMID: 9688062]
  • C Förster, M Rücker, M Shakibaei, I Baumann-Wilschke, J Vormann, R Stahlmann. Effects of fluoroquinolones and magnesium deficiency in murine limb bud cultures. Archives of toxicology. 1998 Jun; 72(7):411-9. doi: 10.1007/s002040050521. [PMID: 9708880]
  • K G Naber, M Well, K Hollauer, D Kirchbauer, W Witte. In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens. Chemotherapy. 1998 Mar; 44(2):77-84. doi: 10.1159/000007096. [PMID: 9551236]
  • B Jacoberger, G Ubeaud, G Freys, T Pottecher, L Jung, J C Koffel. Concentrations of pefloxacin in plasma and tissue after administration as surgical prophylaxis. Antimicrobial agents and chemotherapy. 1998 Feb; 42(2):425-7. doi: 10.1128/aac.42.2.425. [PMID: 9527798]
  • C Imperatore, G R Trimarchi, A De Sarro. Interaction between pefloxacin and aminophylline in genetically epilepsy-prone rats. The Journal of pharmacy and pharmacology. 1997 Oct; 49(10):1025-9. doi: 10.1111/j.2042-7158.1997.tb06035.x. [PMID: 9364414]
  • D Bugnon, G Potel, Y Q Xiong, J Caillon, D Navas, C Gras, M F Kergueris, P Le Conte, F Jehl, D Baron, H Drugeon. Bactericidal effect of pefloxacin and fosfomycin against Pseudomonas aeruginosa in a rabbit endocarditis model with pharmacokinetics of pefloxacin in humans simulated in vivo. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 1997 Aug; 16(8):575-80. doi: 10.1007/bf02447919. [PMID: 9323468]
  • C J Veiopoulou, P C Ioannou, E S Lianidou. Application of terbium sensitized fluorescence for the determination of fluoroquinolone antibiotics pefloxacin, ciprofloxacin and norfloxacin in serum. Journal of pharmaceutical and biomedical analysis. 1997 Aug; 15(12):1839-44. doi: 10.1016/s0731-7085(96)02041-9. [PMID: 9278888]
  • S Huang, L Chen, L Ma. [Study on fluorescence method of pefloxacin]. Guang pu xue yu guang pu fen xi = Guang pu. 1997 Apr; 17(2):45-7. doi: NULL. [PMID: 15810387]
  • E Gautier, J H Bourhis, C Bayle, J Cartron, J L Pico, G Tchernia. Parvovirus B19 associated neutropenia. Treatment with Rh G-CSF. Hematology and cell therapy. 1997 Apr; 39(2):85-7. doi: 10.1007/s00282-997-0085-5. [PMID: 9168305]
  • H Hofbauer, K G Naber, M Kinzig-Schippers, F Sörgel, C Rustige-Wiedemann, B Wiedemann, A Reiz, M Kresken. Urine bactericidal activity of pefloxacin versus norfloxacin in healthy female volunteers after a single 800-mg oral dose. Infection. 1997 Mar; 25(2):121-6. doi: 10.1007/bf02113592. [PMID: 9108190]
  • D Gendrel, J L Moreno, M Nduwimana, C Baribwira, J Raymond. One-dose treatment with pefloxacin for infection due to multidrug-resistant Shigella dysenteriae type 1 in Burundi. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1997 Jan; 24(1):83. doi: 10.1093/clinids/24.1.83. [PMID: 8994771]
  • A Pruna, A Barka, D Nochy, T Hauet, H Boulanger, P Landais. [Pefloxacin as a first-line treatment for nephrotic syndrome in minimal glomerular lesions in the adult. Multicenter study of 32 patients]. Nephrologie. 1997; 18(3):95-101. doi: NULL. [PMID: 9297136]
  • G Tatsis, G Tsoukalas, V Hatzinikolaou, G Boulbasakos, J Jordanoglou. Clinical and microbiological evaluation of pefloxacin in lower respiratory tract infections. The Journal of international medical research. 1996 Nov; 24(6):478-81. doi: 10.1177/030006059602400605. [PMID: 8959532]
  • A C Crémieux, A S Mghir, R Bleton, M Manteau, N Belmatoug, L Massias, L Garry, N Sales, B Mazière, C Carbon. Efficacy of sparfloxacin and autoradiographic diffusion pattern of [14C]Sparfloxacin in experimental Staphylococcus aureus joint prosthesis infection. Antimicrobial agents and chemotherapy. 1996 Sep; 40(9):2111-6. doi: 10.1128/aac.40.9.2111. [PMID: 8878590]
  • E Bertazzoni Minelli, A Benini, A Muner, C Bassi, H Abbas, P Pederzoli. Pefloxacin penetration into human necrotic pancreatic tissue. The Journal of antimicrobial chemotherapy. 1996 Aug; 38(2):237-43. doi: 10.1093/jac/38.2.237. [PMID: 8877537]
  • N Abanmi, I Zaghloul, N El Sayed, K I Al-Khamis. Determination of pefloxacin and its main active metabolite in human serum by high-performance liquid chromatography. Therapeutic drug monitoring. 1996 Apr; 18(2):158-63. doi: 10.1097/00007691-199604000-00009. [PMID: 8721279]
  • E V Cosmi, L Cantini, P A Monici Preti, G C Di Renzo, F Abate, G Balsotti, G Carlomagno, E Cirese, R Indraccolo, G B La Sala, L Mearini, M Minozzi, F Scarpello. Efficacy and tolerability of brodimoprim at two different dosage schedules in the treatment of acute uncomplicated bacterial cystitis: comparative study vs. pefloxacin. European journal of obstetrics, gynecology, and reproductive biology. 1996 Feb; 64(2):207-11. doi: 10.1016/0301-2115(95)02292-9. [PMID: 8820004]
  • M J Pacholczyk, B Lagiewska, J Mészáros, M Szostek, W Rowiński. Bacterial infections transmitted from the donor: antibiotic prophylaxis in the donor. Transplantation proceedings. 1996 Feb; 28(1):184-5. doi: NULL. [PMID: 8644169]
  • J L Moreau, M J Royer-Morrot, A Lozniewski, G Trackoen, P Delavault, R J Royer. Penetration of pefloxacin and its desmethyl metabolite into the uroepithelium after a 800-mg single oral dose in human patients. European journal of clinical pharmacology. 1996; 49(5):401-5. doi: 10.1007/bf00203786. [PMID: 8866637]
  • T Zima, V Tesar, I Rychlík, K Nĕmecek, R Poledne, A Stejskalová, J Tĕmínová, S Stípek, M Merta. [The effect of pefloxacin on nephrotic syndrome in experimental adriamycin nephropathy]. Casopis lekaru ceskych. 1995 Oct; 134(20):658-60. doi: NULL. [PMID: 7489582]
  • J J van de Leur, E J Vollaard, A J Janssen, A S Dofferhoff. Concentration of pefloxacin in feces during infection prophylaxis in neutropenic patients. Antimicrobial agents and chemotherapy. 1995 May; 39(5):1182-4. doi: 10.1128/aac.39.5.1182. [PMID: 7625811]
  • V V Delektorskiĭ, V V Malinovskaia, A N Strizhakov, G N Iashkova, Zh A Kagramanova, D D Genkin, V V Parfenov, D Sh Galiautdinov, A N Balandin, T V Lebedeva. [The interferon inducer neovir (kamedon) in the combined treatment of chronic inflammatory diseases of the adnexa uteri of chlamydial etiology (a clinical electron-microscopic study)]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]. 1995 May; 40(5):42-7. doi: NULL. [PMID: 8534181]
  • G Potel, J Caillon, Y Q Xiong, D Bugnon, P L Conte, H B Drugeon, D Baron. [Critical serum concentration of antibiotics. A therapeutic tool and means of comparative evaluation]. Presse medicale (Paris, France : 1983). 1995 Apr; 24(16):750-2. doi: NULL. [PMID: 7784412]
  • F Scaglione, F Scamazzo, M M Arcidiacono, R Cogo, G P Monzani, F Fraschini. Comparative activities of pefloxacin and ciprofloxacin in the treatment of chronic respiratory tract infections. Journal of chemotherapy (Florence, Italy). 1995 Apr; 7(2):140-5. doi: 10.1179/joc.1995.7.2.140. [PMID: 7666121]
  • C Chidiac, M Roussel-Delvallez, B Guery, G Beaucaire. Should Pseudomonas aeruginosa isolates resistant to one of the fluorinated quinolones be tested for the others? Studies with an experimental model of pneumonia. Antimicrobial agents and chemotherapy. 1995 Mar; 39(3):677-9. doi: 10.1128/aac.39.3.677. [PMID: 7793872]
  • J Guibert. [Efficacy of single dose of ciprofloxacin and pefloxacin in the treatment of female acute cystitis]. Presse medicale (Paris, France : 1983). 1995 Feb; 24(6):304-8. doi: NULL. [PMID: 7899391]
  • Y Q Xiong, G Potel, J Caillon, G Stephant, F Jehl, D Bugnon, P Le Conte, D Baron, H Drugeon. Comparative efficacies of ciprofloxacin and pefloxacin alone or in combination with fosfomycin in experimental endocarditis induced by multidrug-susceptible and -resistant Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy. 1995 Feb; 39(2):496-9. doi: 10.1128/aac.39.2.496. [PMID: 7726520]
  • A Leelarasamee, I Leelarasamee. Comparative efficacies of oral pefloxacin in uncomplicated cystitis. Single dose or 3-day therapy. Drugs. 1995; 49 Suppl 2(?):365-7. doi: 10.2165/00003495-199500492-00100. [PMID: 8549364]
  • Z Korzets, M C Maayan, J Bernheim. Flavobacterial peritonitis in patients treated by peritoneal dialysis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 1995; 10(2):280-3. doi: 10.1093/ndt/10.2.280. [PMID: 7753467]
  • S Mollier, J L Descotes, D Pasquier, P Coquillat, A Michel, S Dalsoglio, J J Rambeaud. Pseudoneoplastic xanthogranulomatous pyelonephritis. A typical clinical presentation but unusual diagnosis and treatment. European urology. 1995; 27(2):170-3. doi: NULL. [PMID: 7744162]
  • F Bressolle, F Gonçalves, A Gouby, M Galtier. Pefloxacin clinical pharmacokinetics. Clinical pharmacokinetics. 1994 Dec; 27(6):418-46. doi: 10.2165/00003088-199427060-00003. [PMID: 7882634]
  • G Panteix, R Harf, J F Desnottes, H Gosselet, M Leclercq, N Diallo, N Couprie, A Desbos, M Perrin Fayolle, M Ballereau. Accumulation of pefloxacin in the lower respiratory tract demonstrated by bronchoalveolar lavage. The Journal of antimicrobial chemotherapy. 1994 May; 33(5):979-85. doi: 10.1093/jac/33.5.979. [PMID: 8089071]
  • U Jaehde, F Sörgel, U Stephan, W Schunack. Effect of an antacid containing magnesium and aluminum on absorption, metabolism, and mechanism of renal elimination of pefloxacin in humans. Antimicrobial agents and chemotherapy. 1994 May; 38(5):1129-33. doi: 10.1128/aac.38.5.1129. [PMID: 8067750]
  • J Raymond, F Moulin, J Badoual, D Gendrel. Eradication of convalescent-phase Salmonella carriage in children with two oral doses of pefloxacin. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 1994 Apr; 13(4):307-10. doi: 10.1007/bf01974606. [PMID: 8070435]
  • D D'Antonio, R Piccolomini, A Iacone, G Fioritoni, G Parruti, S Betti, A M Quaglietta, P Accorsi, M Dell'Isola, C Favalli. Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies. The Journal of antimicrobial chemotherapy. 1994 Apr; 33(4):837-44. doi: 10.1093/jac/33.4.837. [PMID: 8056702]
  • B Lacarelle, C Le Guellec, A Morel, J Albanese, M Alazia, M Ballereau, M Llurens, R Bruno, G Francois, A Durand. Monitoring of pefloxacin serum concentrations in intensive care unit patients: comparison of a new immunoassay with high-performance liquid chromatography. Therapeutic drug monitoring. 1994 Apr; 16(2):209-13. doi: 10.1097/00007691-199404000-00017. [PMID: 8009571]
  • M E Juvin, G Potel, J Caillon, Y Q Xiong, D Bugnon, P Le Conte, D I Baron, H B Drugeon. In vivo bactericidal activities of ciprofloxacin and pefloxacin in an experimental model of Serratia marcescens endocarditis. Antimicrobial agents and chemotherapy. 1994 Apr; 38(4):883-5. doi: 10.1128/aac.38.4.883. [PMID: 8031065]
  • E Ludwig, E Székely, A Csiba. [Clinico-pharmacologic studies on pefloxacin]. Orvosi hetilap. 1994 Mar; 135(13):687-92. doi: NULL. [PMID: 8170669]
  • G Samonis, M Dassiou, H Anastassiadou. Antibiotics affecting gastrointestinal colonization of mice by yeasts. Journal of chemotherapy (Florence, Italy). 1994 Feb; 6(1):50-2. doi: 10.1080/1120009x.1994.11741129. [PMID: 8071679]
  • L Chapuis, J F Cadranel, P Nordmann, H Hagege, D Gargot, B Bernard, C Buffet, D Valla, P Opolon. Grand mal seizures as a complication of treatment with pefloxacin in patients with cirrhosis. A report of three cases. Journal of hepatology. 1993 Nov; 19(3):383-4. doi: 10.1016/s0168-8278(05)80546-x. [PMID: 8151098]
  • M Galtier, F Bressolle, J E de la Coussaye, R Gomeni, P Joubert, F Gény, A Dubois, C Raffanel, G Saissi, J J Eledjam. Multiple-dose pharmacokinetics of pefloxacin in patients with hepatocellular deficiency. Clinical pharmacokinetics. 1993 Nov; 25(5):415-23. doi: 10.2165/00003088-199325050-00007. [PMID: 8287635]
  • J M Osca García, E Broseta Rico, J L Ruiz Cerda, L García Reboll, J Morera Martínez, J M Martínez Jabaloyas, J F Jiménez Cruz. [Antimicrobial prophylaxis in urologic endoscopic surgery: pefloxacin versus ceftriaxone]. Actas urologicas espanolas. 1993 Sep; 17(8):483-6. doi: NULL. [PMID: 8237525]
  • D Delavierre, B Huiban, G Fournier, G Le Gall, D Tande, P Mangin. [The value of antibiotic prophylaxis in transurethral resection of bladder tumors. Apropos of 61 cases]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 1993 Aug; 3(4):577-82. doi: NULL. [PMID: 8401618]
  • M Oncel, G A Peyman. Intravitreal penetration of oral pefloxacin in humans. International ophthalmology. 1993 Aug; 17(4):217-22. doi: 10.1007/bf01007743. [PMID: 8112969]
  • I Cochereau-Massin, J Bauchet, S Marrakchi-Benjaafar, A Saleh-Mghir, F Faurisson, J M Vallois, E Vallee, J J Pocidalo. Efficacy and ocular penetration of sparfloxacin in experimental streptococcal endophthalmitis. Antimicrobial agents and chemotherapy. 1993 Apr; 37(4):633-6. doi: 10.1128/aac.37.4.633. [PMID: 8388193]
  • O Petitjean, B Pangon, N Brion, M Tod, C Chaplain, V Le Gros, K Louchahi, P Allouch. Pharmacokinetics and bactericidal activities of one 800-milligram dose versus two 400-milligram doses of intravenously administered pefloxacin in healthy volunteers. Antimicrobial agents and chemotherapy. 1993 Apr; 37(4):737-40. doi: 10.1128/aac.37.4.737. [PMID: 8494368]
  • A Leroy, J P Fillastre, F Borsa-Lebas, I Etienne, C Gy, G Humbert. [Effect of ketoprofen on the pharmacokinetics of two fluoroquinolones in males]. Pathologie-biologie. 1993 Apr; 41(4):379-84. doi: NULL. [PMID: 8233639]
  • H Giamarellou, D Kanellas, E Kavouklis, G Petrikkos, L Gabriel. Comparative pharmacokinetics of ciprofloxacin, ofloxacin and pefloxacin in human aqueous humour. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 1993 Apr; 12(4):293-7. doi: 10.1007/bf01967262. [PMID: 8513819]
  • N A Lopatkin, A F Darenkov, I I Derevianko, T S Perepanova, G A Kotliarova, T A Nosova. [Clinical effectiveness of pefloxacin (abaktal)in the treatment of inflammatory diseases of the kidneys, urinary tracts and genital organs]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]. 1993 Feb; 38(2-3):44-9. doi: NULL. [PMID: 8074566]